Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh 15-17 March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa.

Slides:



Advertisements
Similar presentations
Global Measles and Rubella Strategic Plan
Advertisements

1 June 2011 Measles update- India Dr. Satish Kumar Gupta Health Specialist UNICEF- India 13 th September 2011.
Immunization Services DR. KANUPRIYA CHATURVEDI DR.S.K. CHATURVEDI.
1 Dr. Azhar Abid Raza Washington Sept 2011 Measles elimination in Pakistan.
Monitoring progress towards the coverage and disease incidence targets GLOBAL MEASLES AND RUBELLA MANAGEMENT MEETING March 2011 Geneva, Switzerland.
Measles and Rubella Elimination in the WHO European Region: Update on Progress & Challenges Global Measles and Rubella Management Meeting March 2011.
Reproductive and Child Health (R&CH) Presented by: Dr. Mariam J. Bakar & Mr. Yusuph Haji.
Measles outbreak investigation & Response Jordan DR MOHAMAD RATIB SUROUR NATIONAL EPI MANAGER INTER-COUNTRY MEETING ON MEASLES AND RUBELLA CONTROL AND.
The Cape Verde experience with rubella outbreak & lessons from introducing rubella vaccines MoH Cape Verde ARCI meeting Dar es Salaam, Tanzania Dec 2012.
A global partnership to stop measles & rubella The Measles & Rubella Initiative: Preparing for the Next Decade Lisa Cairns, MD, MPH Sept 18, 2012 Washington,
Strengthening Routine Infant Immunization in EMR Partners for Measles Advocacy February, 2007 Eastern Mediterranean Regional Office Vaccines Preventable.
MINISTRY OF COMMUNITY DEVELOPMENT MOTHER AND CHILD HEALTH MRS. ELIKA KAMIJI CHIEF EPI OFFICER IMPLEMENTATION OF GAPPD: ZAMBIAN EXPERIENCE Global Immunization.
Proceedings of the SAGE Working Group on Rubella Vaccines Susan E. Reef, MD Global Measles and Rubella Management Meeting March 15, 2011.
Supporting Routine AND Supplementary Immunization Activities in STOP.
21 st May pm WHO conference room Expanded Program on Immunization.
OIC-SHPA & Vaccines Need Assessment in OIC Member Countries
Ann Levin, Colleen Burgess, Lou Garrison, Chris Bauch, and Joseph Babigumira Measles Initiative Meeting Washington, D.C. September 13,
A Comprehensive Policy framework for the National Immunization Programme Dr Nihal Abeysinghe, [M.B.,B.S., MSc, M.D.] Chief Epidemiologist, Ministry of.
Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, September 2008.
Measles Initiative Financing February 28, 2007 Washington, D.C. Andrea Gay UN Foundation for Measles Partners.
Progress towards Sustainable Measles Mortality Reduction South-East Asia Region Jayantha Liyanage Medical Officer- EPI Immunization and Vaccine Development.
What is “Reaching Every District” (RED) in Immunization? A brief overview Information from the global immunization partnership presented by Lora Shimp.
1 1 Measles elimination and rubella control in the SEA Region- a brief Update 12 th Annual Meeting of the Measles Rubella Initiative (MRI) September,
Immunization service delivery – immunization management prospective.
IMMUNIZATION IN UGANDA Dan Wamanya IMMUNIZATION IN UGANDA Dan Wamanya USAID/Uganda.
Update on the Implementation of Measles 2 nd Dose in India Ms. Anuradha Gupta Joint Secretary, Ministry of Health Govt. of India Global Measles and Rubella.
Multi-Year Plans Strengthening immunization systems and introduction of hepatitis B vaccine in Central Europe and the Newly Independent States St. Petersburg,
Edward J. Hoekstra, MD, MSc Edward J. Hoekstra, MD, MSc Senior Health Advisor Senior Health Advisor UNICEF HQ, New York UNICEF HQ, New York Peter Strebel,
Palestine Bahrain Global Measles and Rubella Management Meeting Boubker Naouri March, 2011 Geneva, WHO HQ.
MEASLES MORTALITY REDUCTION IN INDIA Status and Future Plans.
Current Status of Immunization Service Delivery in Africa Mary Harvey AFR/SD/HRD SOTA/PHN Meeting June 13, 2002.
Update on Measles Mortality Reduction Activities and Linkages with RI.
Conclusions of the meeting and closing remarks. Chronology 1981Hepatitis B vaccine becomes available 1991World Health Assembly resolution call for the.
Measles Initiative Management and Financing September 13, 2011.
14 th Measles and Rubella Initiative Meeting Mona Aryal HOD, Health Service Department Nepal Red Cross Society National Headquarter Nepal Red Cross Society’s.
JAHSR TECHNICAL REVIEW MEETING EPI Report Dr Dafrossa C Lyimo Programme Manager 7th September 2010 Dar es salaam.
Measles elimination Dr. As’ad Ramlawi Palestine..
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
Funding Update: 2013 – 2015 September 10,
WHO Regional Office for Europe Update on WHO GAVI European Regional Working Group and hepatitis B Immunization Viral Hepatitis Prevention Board Meeting.
Global Overview of Measles & Rubella 11 th Annual Meeting The Measles Initiative Washington, DC th September, 2012.
APPLYING LESSONS LEARNED TO FOLLOW-UP CAMPAIGNS, NIGERIA
1 |1 | Measles pre-elimination and resurgence in the African region Balcha Masresha IVD AFRO Global Measles Management Meeting Geneva March 2011.
Status of EPI In Guinea DR. Mariama BAH Child Survival Advisor USAID/Guinea June 13, 2002.
India: Transitioning of Polio Network to Support Other Immunization Activities Jeffrey W McFarland, MD Regional Advisor, WHO South-East Asia Regional Office.
Sudan EPI Benefits From Polio Eradication Program M&RI Annual Partners Meetings Washington D.C September 2015 Sudan EPI Benefits From Polio Eradication.
Update on Progress toward Measles Situation in EMR September 2008 Dr B. Naouri VPI/DCD/EMRO.
GHANA HEALTH SERVICE, EASTERN REGION MID-YEAR REVIEW 2014 WAY FORWARD BY RDHS.
Integrated Measles Best Practice SIA 2010/2011 Experience from Ethioipia Global Measles and Rubella Meeting, March 2011, Geneva.
Measles Mortality Reduction: the risk of resurgence Global Immunization Meeting Geneva, Switzerland 1-3 February 2010 Balcha Masresha, WHO/AFRO.
2015 Measles & Rubella Initiative Annual Partners Meeting, Human & Financial Costs of Measles and Rubella, 15 September 2015, Washington, DC Achieving.
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
IMCI Implementation in Ghana Initial assessment 1998 Adaptation phase ( ) Early implementation ( ): 4 focus districts Scale-up: 5-year.
12 th Annual Meeting of The Measles & Rubella Initiative American Red Cross, Washington, DC September, 2013.
Sustaining the gains and reaching milestones on the way towards elimination of measles and rubella 15 September 2015 Dr Peter Strebel, WHO, IVB/EPI.
Measles and Rubella Initiative Financial Resource Requirements for Measles and Rubella Annual Partners Meeting, September
New Vaccine Introduction ‘MR vaccine introduction in Kenya’
PROGRESS TOWARDS MEASLES & RUBELLA ELIMINATION EXPERIENCE FROM OMAN SALAH AL AWAIDY, MD COMMUNICABLE DISEASES ADVISOR MOH, OMAN
World Health Organization Western Pacific Regional Office Expanded Programme on Immunization Measles Elimination in the Western Pacific Region 2007 Partners.
EBOLA OUTBREAK – LIBERIA, Current Status Scale and evolution of outbreak outpacing strategy and plans – 14 of 15 counties now affected – Major urban.
Accelerating Progress towards Measles and Rubella Elimination Eastern Mediterranean Region 1 21 June 2016 Geneva, Switzerland.
Global Measles and Rubella: Highlights, Priorities and Critical Issues
Measles mortality reduction in SEAR
Measles & Rubella Initiative Partners meeting September 7-8, 2017
<COUNTRY NAME> EPI REVIEW
African Region- priorities to reach the 2020 measles elimination goal.
Funding Update: Current Situation and Future Prospects
State of Measles Initiative Financing Partners for Measles Advocacy Meeting Washington, D.C. September 22, 2008 Andrea Gay.
Partners for Measles Advocacy—7th Annual Meeting
STRATEGIES AND PROGRESS
Presentation transcript:

Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa

Measles control plan ( ) and next goals in Bangladesh Measles catch-up campaign immunized: >35 million Measles follow-up campaign immunized: >18 million plus OPV, vit A,albendazole Measles control plan In , cMYP elimination target Including 2 nd dose MCV2 introduction cMYP Source: Child deaths due to measles by WHO estimation, 10 Feb %

Trends of measles cases and valid measles coverage by one year of age ( ) Measles catch-up campaign immunized: >35 million Measles follow-up campaign immunized: >18 million

Dots are randomly placed within district boundary Spot Map of Outbreaks Reported in Bangladesh Measles catch-up campaign immunized: >35 million Measles follow-up campaign immunized: >18 million Year # of measles outbreaks ( lab) and ( mixed) # of rubella outbreaks

Age Distribution of Lab Confirmed Measles Outbreak Cases, Bangladesh, * No Laboratory Confirmed Measles Outbreak detected in 2007 N=523 (12) N=5,248 (68) N=9,378 (120) N=2,095 (34) N=132 (1) N=48 (1) No Laboratory Confirmed Measles Outbreak detected in 2010

Vaccination Status of Lab Confirmed Outbreak Cases, Bangladesh, No Laboratory Confirmed Measles Outbreak detected in 2007 No Laboratory Confirmed Measles Outbreak detected in 2010

Measles Cases in Bangladesh by Year Changes in definition of outbreak: 2003: 50 cases per ward 2005:10 cases per ward 2008: 3 cases per ward Outbreak surveillance Case based surveillance Measles catch-up campaign immunized: >35 million Measles follow-up campaign immunized: >18 million

Measles surveillance indicators

Virus isolation status YearNo. of urine Sample collected Sample tested in regional lab MeaslesRubellaNegativePending

Non-measles suspected cases reporting rate % (37/64) districts achieved rate ≥2.00 in 2010

Measles vaccination valid coverage by 12 months of age, 2005 and 2010 Source: CES 2005 and % (52/64) districts achieved ≥80% coverage in 2010

Challenge to improve Surveillance indicators Measles case based surveillance -Integrated with AFP and other VPD Challenge: financial sustainability and transition of VPD network parallel to health systems 140 facilities included for weekly active surveillance for AFP, NT and Measles- at the same time they are reporting 6 EPI diseases on weekly basis All 471 Upazila Health Complexes (UHCs) included in weekly passive reporting 156 additional facilities conduct weekly passive reporting VPD surveillance supported by WHO funded network of 42 SMOs

ICDDRB study on Impact of Measles Activities on Routine Immunization Services and Health Systems in Bangladesh T. Koehlmoos et al. The Journal of Infectious Diseases ( in press) Conclusion: Measles elimination activities had enormous positive impacts on immunization programme and health systems of Bangladesh Effective integration of the immunization programme with health systems, high level political commitment and effective inter-agency collaboration contributed the campaigns successful Examples of impacts: Governance Strengthened inter-ministerial coordination and collaboration Effective collaboration between MOHFW and development partners Increased involvement of other sectors in immunization programme ICC becomes more active Raised awareness among political leaders Improved accountability of staff members of the EPI programme Planning and management Improved skills of staff to develop strategies in EPI planning at national to local level Improved skills to management of mass campaigns Identifying and mapping of target and hard-to-reach population for other EPI outreach activities Stimulate interdepartmental & inter-sectoral planning Better long term planning of financing EPI service delivery Injection safety Management & surveillance of AEFI Increased awareness among community members due to huge publicity Delivery of add-on’s interventions (vitamin A, deworming, OPV) Increased EPI centres and clinic visits of people after campaigns resulted to do less motivational works

ICDDRB study (cont’d) Examples of impacts Impact on Logistics New equipments were kept as fixed assets for routine immunization Training and technical assistance to the local staff increased their skills and confidence to maintain cold chain Impact on Financing Helped to develop skills in fund- raising from local and international partners Funding or in-kind support for campaigns release money for other EPI activities Motivated government & other funders to invest more money in EP Impact on human resources Positive Increased stock of EPI workforce/volunteers Contributed development of inter-personal communication among the staff members of different sectors Created opportunity for staff members involved from other department of MOHFW to learn more about EPI Negative Staff members de-motivated from late arrival of funding EPI staff feel overloaded with added works Shortage of technical staff The campaigns did not attract a sufficient number of volunteers in some areas as their refreshment fund were not enough

Budget for integrated VPD surveillance and measles activities in ( in million USD) plannedavailablegapplannedavailablegapplannedavailabl e gap MCV 2 vaccine Bangladesh will apply to GAVI for MCV2 cost support MR vaccineBangladesh consider the cost of MR vaccine to be born from new Health Sector Programme for MCV2 Introduction -Training & supervision 1,220 surveillance2,52,00,52, ,01.3 Total gap0.5Total gap1.52Total gap 1.3 Total Gap for ,32 million USD

Thank You

WHO estimates on measles death in Bangladesh Measles catch-up campaign immunized: >35 million Measles follow-up campaign immunized: >18 million Measles control plan In , cMYP elimination target Including 2 nd dose MCV2 introduction cMYP Source: Child deaths due to measles by WHO estimation, 10 Feb 2011

2011 Plans and budget Measles initiative co-financed activities of WHO surveillance network in No funds for specific measles surveillance strengthening activities in In 2011 WHO SMOs network will continue support the current level of measles in integration with AFP surveillance. No donor’s commitment to support surveillance network after 2012

Budget for integrated (AFP/Measles/Other VPDs) surveillance and measles control/ elimination activities ActivitiesFund required yearly Fund required one time 2012 Fund availableFunding gap Funding gap one time Annual Surveillance operational cost 2.5 million1.5 million x2 l (in ) 9,5 million MCV2Government will apply for GAVI support for vaccine MCV2 Introduction- Training & supervision 1.22 million 0 Logistics –printings and others for MCV2 Cost is under consideration for next health sector program MR vaccineVaccine Cost is under consideration for next health sector program Measles SIA No plan developed Total million1.22 million 3 million9,5 million1.22 million Total Gap10,72 million

Advocacy Plans and Opportunities Advocate to include measles elimination activities in the new national health sector development plan for including : Funds for surveillance activities Create national position of district immunization and surveillance medical officers (DISMO) Introduce MR vaccine and allocate cost in the health sector plan EPI will apply for GAVI support on MCV-2 introduction Advocate for donors support of WHO surveillance network to maintain current activities and during the transition to DISMOs